CEN Biotech, Inc. (CENBF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCEN Biotech, Inc. (CENBF) trades at $0.0003. CEN Biotech, Inc. is a Canadian company focused on the development of LED lighting technology and hemp-based products. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for CENBF: CENBF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CEN Biotech, Inc. (CENBF) Healthcare & Pipeline Overview
CEN Biotech, Inc. specializes in the manufacture and development of LED lighting technology and hemp-based products, positioning itself within the growing healthcare sector focused on industrial and medical applications.
What Is the Investment Thesis for CENBF?
CEN Biotech, Inc. operates in a niche market focusing on LED technology and hemp-based products, which are gaining traction due to their sustainability and health benefits. The company’s gross margin stands at 50.5%, indicating a potential for profitability as it scales operations. With the increasing legalization and acceptance of hemp products in various sectors, CEN Biotech is well-positioned to capitalize on this trend. However, the company faces challenges, including a negative profit margin of -153.5%, which necessitates careful management of its operational costs. The company's growth will depend on its ability to expand its product offerings and market reach while managing risks associated with the volatile hemp market.
Based on FMP financials and quantitative analysis
CENBF Key Highlights
Gross margin of 50.5% indicates strong potential for profitability as operations scale.
- Negative profit margin of -153.5% highlights the need for cost management and operational efficiency.
- Market Cap is currently at $0.00B, reflecting the early-stage nature of the business.
- Small workforce of 4 employees allows for agile decision-making and adaptation to market changes.
- Focus on both LED technology and hemp products diversifies revenue streams.
Who Are CENBF's Competitors?
CENBF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CURLF Curaleaf Holdings, Inc. | $9.95 | -3.24% | $2.63B | — |
| APHA APHA | $15.27 | -1.04% | — | |
| TLRY Tilray Brands, Inc. | $3.61 | +1.12% | $404M | — |
| TAK Takeda Pharmaceutical Company Limited | $17.86 | 0.00% | $56.8B | 64 5-pillar |
| TEVA Teva Pharmaceutical Industries Limited | $39.53 | +0.56% | $46.0B | 66 5-pillar |
| HLN Haleon plc | $8.80 | +0.92% | $38.8B | 78 5-pillar |
| ZTS Zoetis Inc. | $69.69 | +0.85% | $29.2B | 87 5-pillar |
| VTRS Viatris Inc. | $17.60 | +0.80% | $20.5B | 32 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CENBF's Key Strengths?
Strong gross margin of 50.5% indicates potential profitability.
- Diverse product offerings in both LED and hemp markets.
- Agile business model with a small workforce.
What Are CENBF's Weaknesses?
Negative profit margin of -153.5% necessitates operational improvements.
- Limited brand recognition in a competitive market.
- Small team may limit scalability.
What Are the Key Risks for CENBF?
Financial-distress signal — its Altman Z-Score of -9.90 sits in the distress zone (elevated bankruptcy risk).
- Regulatory changes affecting the hemp market could impact operations.
- Competition in the LED and hemp sectors may pressure margins.
- Market volatility in hemp prices could affect profitability.
What Are CENBF's Competitive Advantages?
- Focus on innovative and sustainable product offerings.
- Small team allows for quick adaptation to market changes.
- Diverse revenue streams mitigate risks associated with market fluctuations.
- Niche positioning in the growing hemp market.
- Expertise in both technology and agriculture sectors.
What Does CENBF Do?
CEN Biotech, Inc. was incorporated in 2013 and is headquartered in Windsor, Canada. The company focuses on the manufacture, production, and development of light-emitting diode (LED) lighting technology alongside hemp-based products intended for industrial, medical, and food applications. CEN Biotech aims to leverage the growing demand for hemp-derived products, which are increasingly recognized for their potential health benefits and versatility in various industries. The company also offers digital marketing and web design services, further diversifying its business model. With a small team of four employees, CEN Biotech is positioned to adapt quickly to market changes and innovations. As the healthcare sector evolves, the demand for sustainable and innovative solutions, such as those offered by CEN Biotech, is likely to increase, providing the company with potential growth avenues. The company’s dual focus on technology and agricultural products allows it to tap into multiple revenue streams, catering to a diverse clientele.
What Products and Services Does CENBF Offer?
- Manufacture and develop LED lighting technology.
- Cultivate hemp for industrial, medical, and food applications.
- Provide digital marketing and web design services.
- Focus on sustainable and innovative product offerings.
- Serve diverse customer segments across multiple industries.
- Adapt to market changes with a small, agile team.
How Does CENBF Make Money?
- Generate revenue through the sale of LED lighting products.
- Cultivate and sell hemp-based products to various sectors.
- Offer digital marketing and web design services to businesses.
- Leverage market trends in sustainability and health.
- Diversify revenue streams to reduce dependency on a single market.
What Industry Does CENBF Operate In?
The healthcare industry, particularly in the drug manufacturing sector, is experiencing significant growth driven by increasing consumer demand for natural and sustainable products. The market for hemp-derived products is projected to expand rapidly, with a growing acceptance of cannabis-based therapies across various regions. CEN Biotech, Inc. is positioned within this evolving landscape, where competition is intensifying as more companies enter the hemp market. The drug manufacturers' segment is expected to see a compound annual growth rate (CAGR) of over 15% in the coming years, driven by innovation and regulatory changes. CEN Biotech's focus on both LED technology and hemp products allows it to tap into multiple growth avenues within the healthcare sector.
Who Are CENBF's Key Customers?
- Businesses seeking LED lighting solutions.
- Industrial clients requiring hemp for manufacturing.
- Medical companies looking for hemp-derived products.
- Food producers interested in hemp ingredients.
- Companies needing digital marketing and web design services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
CEN Biotech, Inc. operates in the Healthcare sector. It is headquartered in Windsor, CA. The company is led by CEO Brian S. Payne. CENBF has traded publicly since 2020.
Key Financial Metrics
Return on assets is -10.1%, showing how much profit it generates from its asset base. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
CEN Biotech, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -9.90 places it in the distress zone, a signal of elevated financial risk.
CENBF Financials
CENBF Latest News
No recent news available for CENBF.
CENBF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CENBF.
Price Targets
Wall Street price target analysis for CENBF.
CENBF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CENBF; grades run from A+ (80-100) to F (below 30).
Leadership: Brian S. Payne
CEO
Brian S. Payne has been at the helm of CEN Biotech, Inc. since its inception in 2013. With a background in business management and technology, he has guided the company through its early stages of development. His experience encompasses various roles in the healthcare and technology sectors, providing him with a unique perspective on market dynamics.
Track Record: Under Brian's leadership, CEN Biotech has established itself in the niche markets of LED technology and hemp products. His strategic decisions have focused on product innovation and market expansion, positioning the company to capitalize on emerging trends.
CENBF OTC Market Information
The OTC Other tier includes companies that do not meet the stringent listing requirements of major exchanges like NYSE or NASDAQ. This tier allows for greater flexibility but may involve higher risks due to less regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosures may lead to uncertainty regarding the company's financial health.
- Lower liquidity can result in higher volatility and difficulty in executing trades.
- Regulatory risks associated with operating in the hemp market.
- Verify the company's financial statements and disclosures.
- Assess the management team's experience and track record.
- Investigate the competitive landscape and market positioning.
- Review regulatory compliance related to hemp cultivation.
- Evaluate the company's growth strategy and market opportunities.
- Incorporated in 2013, indicating a level of operational stability.
- Focus on innovative technologies and sustainable products.
- Engagement in multiple revenue streams reduces dependency on a single market.
CENBF Healthcare Stock FAQ
What revenue streams does CEN Biotech, Inc. have in healthcare?
CEN Biotech, Inc. generates revenue through multiple streams, including the sale of LED lighting products, cultivation and sale of hemp-based products, and offering digital marketing and web design services.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial disclosures may affect the reliability of financial assessments.